Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect.

Gunderson SM, Hoffman H, Ernst EJ, Pfaller MA, Klepser ME.

Antimicrob Agents Chemother. 2000 Oct;44(10):2887-90.

2.

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.

Gil-Alonso S, Jauregizar N, Eraso E, Quindós G.

PLoS One. 2015 Jul 13;10(7):e0132730. doi: 10.1371/journal.pone.0132730. eCollection 2015.

3.
4.

The in vitro post-antifungal effect of nystatin on Candida species of oral origin.

Ellepola AN, Samaranayake LP.

J Oral Pathol Med. 1999 Mar;28(3):112-6.

PMID:
10069538
5.
6.
7.

Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates.

Nguyen KT, Ta P, Hoang BT, Cheng S, Hao B, Nguyen MH, Clancy CJ.

Antimicrob Agents Chemother. 2009 Aug;53(8):3347-52. doi: 10.1128/AAC.01480-08. Epub 2009 Apr 13.

8.

The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates.

Ellepola AN, Joseph BK, Chandy R, Khan ZU.

Mycoses. 2014 Jan;57(1):56-63. doi: 10.1111/myc.12102. Epub 2013 Jun 17.

PMID:
23773155
9.
10.

Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.

Ellepola AN, Khajah R, Jayatilake S, Samaranayake L, Sharma P, Khan Z.

J Appl Oral Sci. 2015 Jul-Aug;23(4):412-8. doi: 10.1590/1678-775720150100.

11.

Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species.

Shu M, Ellepola AN, Samaranayake LP.

J Clin Microbiol. 2001 Jul;39(7):2732-5.

12.
13.
14.

In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.

Choukri F, Benderdouche M, Sednaoui P.

J Mycol Med. 2014 Dec;24(4):303-7. doi: 10.1016/j.mycmed.2014.05.001. Epub 2014 Oct 23.

PMID:
25442913
15.

In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods.

Lewis RE, Klepser ME, Pfaller MA.

Diagn Microbiol Infect Dis. 2000 Feb;36(2):101-5.

PMID:
10705051
16.

Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.

Kardos T, Saleh Q, Kovács R, Gesztelyi R, Kardos G, Bozó A, Tóth Z, Majoros L.

New Microbiol. 2017 Oct;40(4):286-288. Epub 2017 Oct 10.

17.

SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.

Scorneaux B, Angulo D, Borroto-Esoda K, Ghannoum M, Peel M, Wring S.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01961-16. doi: 10.1128/AAC.01961-16. Print 2017 Mar.

18.

In vitro susceptibility and resistance of Candida spp. to hamycin.

Athar MA.

Sabouraudia. 1971 Nov;9(3):256-62. No abstract available.

PMID:
4944203
19.

In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies.

Ernst EJ, Roling EE, Petzold CR, Keele DJ, Klepser ME.

Antimicrob Agents Chemother. 2002 Dec;46(12):3846-53.

20.

Occidiofungin's chemical stability and in vitro potency against Candida species.

Ellis D, Gosai J, Emrick C, Heintz R, Romans L, Gordon D, Lu SE, Austin F, Smith L.

Antimicrob Agents Chemother. 2012 Feb;56(2):765-9. doi: 10.1128/AAC.05231-11. Epub 2011 Nov 21.

Supplemental Content

Support Center